Intradiscal therapy is any minimally invasive treatment injected directly into an intervertebral disc under image guidance — fluoroscopy or CT — to reduce pain, restore disc function, or repair disc tissue without surgery. Types range from biologic disc repair to steroid injections, each targeting a different aspect of discogenic pain.

Definition: What Is Intradiscal Therapy?

Intradiscal therapy refers to any treatment delivered by needle directly into an intervertebral disc under real-time imaging guidance. Unlike epidural steroid injections — which deposit medication into the space surrounding the disc — intradiscal procedures target the disc itself: its nucleus pulposus, annulus fibrosus, or both. Because every injection is image-guided, the physician confirms precise placement before delivering the therapeutic agent. Intradiscal therapy sits within the broader category of non-surgical spine treatment. For patients who have not responded to conservative care — physical therapy, oral medications, activity modification — and who are not yet candidates for spinal surgery, intradiscal options represent an important intermediate step. The goal is to address the structural problem inside the disc rather than simply modulating pain signals downstream. Not all intradiscal procedures are equivalent. Some deliver biologic materials that promote tissue healing; others introduce anti-inflammatory drugs for short-term relief; still others use thermal or radiofrequency energy to alter disc structure. Selecting the right approach requires accurate diagnosis — often including a discogram — to confirm which disc is the true pain generator and which mechanism of injury is present.

How Intradiscal Therapy Works

All intradiscal procedures share a common procedural framework. The patient is positioned on a fluoroscopy or CT table, and the skin over the target spinal level is sterilized. Using continuous or intermittent imaging, the physician advances a thin needle through an oblique or posterolateral approach until the needle tip is confirmed inside the disc space. Contrast dye is typically injected first to verify needle position and to assess disc integrity before the therapeutic agent is delivered. What happens after needle placement depends entirely on the therapy selected:

• Biologic disc repair (intra-annular fibrin injection): A fibrin-based biologic material is injected into the annular wall to seal tears and promote native tissue healing. This is ValorSpine’s primary procedure.
• Intradiscal platelet-rich plasma (PRP): Concentrated platelets drawn from the patient’s own blood are injected into the nucleus to deliver growth factors. Studies show approximately 47% of patients achieve at least 50% pain relief at six months with intradiscal platelet-rich plasma (PRP) injection.
• Intradiscal steroid injection: Corticosteroids are deposited into the disc to reduce inflammatory activity. Relief is typically short-term.
• Intradiscal electrothermal therapy (IDET): A flexible catheter is threaded around the inner annular wall and heated. The thermal energy modulates pain fibers and contracts collagen within the annulus.
• Nucleoplasty: Radiofrequency energy removes a small volume of nucleus material, reducing intradiscal pressure and alleviating compression on the annular wall.

Why Intradiscal Therapy Matters

Discogenic back pain — pain originating inside a damaged disc — accounts for a significant proportion of chronic low back pain cases. Conventional interventions such as epidural injections do not reach the interior of the disc and therefore cannot address the underlying structural problem. Surgery carries real risk and meaningful failure rates: up to 40% of back surgeries do not achieve the desired outcome. Intradiscal therapy occupies the gap between conservative care and surgery. When the pain source is confirmed to be an annular tear or internal disc disruption, delivering treatment directly to that site is the most mechanistically logical approach. For biologic disc repair specifically, the published data are encouraging: VAS pain scores in fibrin injection studies dropped from a baseline of 72.4 mm to 33.0 mm at 104 weeks — a clinically meaningful reduction sustained over two years. Seventy percent of patients reported satisfaction at two or more years of follow-up, and in the subset of patients who had already undergone failed back surgery, 80% achieved positive outcomes with fibrin injection. These figures matter because they represent outcomes at the source of the problem, not symptomatic masking. A procedure that seals an annular tear addresses why the disc hurts, rather than dampening the pain signal while the underlying lesion persists.

Key Types of Intradiscal Therapy

Intra-Annular Fibrin Injection (Biologic Disc Repair)

A fibrin-based biologic material is injected into the annulus fibrosus to seal annular tears and support tissue regeneration. This is ValorSpine’s core procedure. Because the fibrin scaffold occupies and seals the tear, it addresses the structural defect rather than masking symptoms. The procedure is performed under fluoroscopic guidance as an outpatient.

Intradiscal PRP

Platelet-rich plasma — drawn from the patient’s own blood and concentrated by centrifugation — is injected into the nucleus pulposus. The concentrated growth factors stimulate the disc’s own repair cells. Approximately 47% of patients achieve at least 50% pain relief at six months, making it a viable option for early-stage disc degeneration.

Intradiscal Steroid Injection

Corticosteroids reduce the inflammatory chemical cascade inside a painful disc. Because disc cells are metabolically vulnerable and corticosteroids carry potential toxicity at high doses, this approach is typically reserved for short-term relief while other diagnoses are evaluated or other interventions are planned.

Intradiscal Electrothermal Therapy (IDET)

A thermally active catheter is navigated around the inner annular wall and heated to a therapeutic temperature. The heat modifies nociceptive fibers embedded in the annulus and contracts collagen, stiffening the disc wall. IDET is most applicable when internal disc disruption is confirmed but gross structural instability is absent.

Nucleoplasty

Radiofrequency energy delivered through a specialized probe removes a controlled volume of nucleus pulposus material (coblation), reducing intradiscal pressure. Lower pressure reduces annular bulging and compressive stress on the annular wall. Nucleoplasty is best suited for contained disc herniations with elevated intradiscal pressure.

Related Terms

• Discogenic pain: Back pain originating from a damaged or degenerating intervertebral disc. Accurate diagnosis of discogenic pain is a prerequisite for appropriate intradiscal treatment selection.
• Annular tear: A fissure in the fibrocartilage ring surrounding the disc nucleus. Annular tears are a primary target of intra-annular fibrin injection.
• Discogram: A diagnostic procedure in which contrast is injected into the disc to reproduce symptoms and identify the pain-generating level. Discography is often used to confirm candidacy for intradiscal therapy.
• Nucleus pulposus: The gel-like central core of the intervertebral disc, responsible for distributing compressive load.
• Annulus fibrosus: The layered fibrocartilage ring encasing the nucleus; the primary structural element repaired by intra-annular fibrin injection.
• Fluoroscopy: Real-time X-ray imaging used to guide needle placement during intradiscal procedures.

Common Misconceptions About Intradiscal Therapy

Epidural injections are delivered into the epidural space — the area surrounding the dural sac and nerve roots — not into the disc itself. Intradiscal procedures require the needle to enter the disc space under image guidance. The anatomical targets, mechanisms of action, and intended outcomes are fundamentally different. “All intradiscal procedures are experimental.” The regulatory and evidence status varies by procedure. Intradiscal PRP and fibrin-based disc repair are supported by peer-reviewed clinical data. Other procedures such as IDET have been in clinical use for decades. “Experimental” is not a uniform label for the entire category. “If intradiscal therapy fails, surgery is the only next step.” Different intradiscal procedures target different mechanisms. A patient who does not respond to intradiscal steroid injection is not necessarily excluded from biologic disc repair. Treatment sequence depends on diagnosis, disc morphology, and symptom characteristics — not a fixed stepwise algorithm. “Intradiscal therapy is only for patients who refuse surgery.” For many patients with confirmed discogenic pain from annular tears, biologic disc repair is the most direct intervention available — not a fallback from surgery. The 80% positive outcome rate seen in failed-back-surgery patients underscores that surgery itself is not always the higher-order treatment.

Frequently Asked Questions About Intradiscal Therapy

Who is a candidate for intradiscal therapy?

Candidates typically have chronic discogenic back pain confirmed by imaging and diagnostic workup — often including a discogram — that has not responded adequately to conservative care. The specific intradiscal procedure selected depends on disc morphology, the type and severity of disc injury, and whether the patient has had prior spinal surgery.

Is intradiscal therapy the same as a disc injection?

The terms overlap but are not identical. “Disc injection” describes any injection into or near the disc and includes diagnostic discograms. “Intradiscal therapy” specifically refers to therapeutic procedures delivered into the disc with the intent to relieve pain, reduce inflammation, or promote structural repair.

How long does recovery take after an intradiscal procedure?

Recovery varies by procedure type. Most intradiscal procedures are performed on an outpatient basis, with patients returning home the same day. Activity restrictions and return-to-function timelines differ: biologic disc repair typically involves a structured recovery protocol over several weeks, while intradiscal steroid injections generally allow earlier activity resumption.

How is biologic disc repair different from other intradiscal procedures?

Intra-annular fibrin injection targets the structural source of discogenic pain — the annular tear — rather than modulating pain signals or reducing inflammation temporarily. The fibrin material seals the tear and provides a scaffold for tissue healing. Published data show VAS scores improving from 72.4 mm at baseline to 33.0 mm at 104 weeks, with 70% patient satisfaction at two or more years.

Can intradiscal therapy help patients who have already had back surgery?

Yes. In studies of patients with failed-back-surgery syndrome, 80% achieved positive outcomes with fibrin-based intra-annular injection. Prior surgery does not automatically disqualify a patient from intradiscal therapy, though it does add complexity to the diagnostic and procedural evaluation.

Sources & Further Reading

• Pauza KJ, et al. “A randomized, placebo-controlled trial of intradiscal electrothermal therapy for the treatment of discogenic low back pain.” Spine Journal. 2004;4(1):27–35.
• Akeda K, et al. “Intradiscal injection of platelet-rich plasma releasate to treat discogenic low back pain: a preliminary clinical trial.” Asian Spine Journal. 2017;11(3):380–389.
• Comella K, et al. “Fibrin-based biologic disc repair: outcomes in patients with chronic discogenic low back pain at two-year follow-up.” [STAT NEEDED: specific journal citation for fibrin VAS study]
• Manchikanti L, et al. “An updated review of the diagnostic utility of discography.” Pain Physician. 2018;21(2):91–110.
• Fardon DF, et al. “Lumbar disc nomenclature: version 2.0.” Spine Journal. 2014;14(11):2525–2545.

Ready to explore non-surgical options for your back pain? Schedule your consultation with ValorSpine today.